The impact of no-reflow phenomena after primary percutaneous coronary intervention
Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital), Ki‐Bae Seung, Doo Soo Jeon(Catholic University of Korea), Ki‐Dong Yoo(The Catholic University of Korea St. Vincent's Hospital), Youngkeun Ahn(Chonnam National University Hospital), Dong‐Bin Kim(St. Paul's Hospital), Sung‐Ho Her(St. Mary's Hospital), Jong Min Lee(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Chul Soo Park(Asan Medical Center), Myung Ho Jeong(Veterans Health Service Medical Center), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Pum Joon Kim(St. Paul's Hospital), Kiyuk Chang(St. Mary's Hospital)
Cited by 42
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510